Related Experiment Video

Updated: Jun 10, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

SnoN/SkiL, a TGFβ signaling mediator: a participant in autophagy induced by arsenic trioxide

Fadi Raffoul1, Christie Campla, Meera Nanjundan

  • 1Department of Cell Biology, Microbiology and Molecular Biology, University of South Florida, Tampa, FL, USA.

Autophagy
|August 12, 2010
PubMed

Insights

Arsenic trioxide induces cancer cell death in ovarian carcinomas by modulating SnoN/SkiL expression, activating a Beclin 1-independent autophagic pathway. This implicates SnoN as a potential therapeutic target for ovarian cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Mechanisms

Background:

  • Effective cancer treatment requires understanding drug-induced cell death mechanisms.
  • Arsenic trioxide (As(2)O(3)) is cytotoxic to ovarian cancer cells, but its mechanism is unclear.
  • Transforming growth factor-β (TGFβ) signaling is often dysregulated in ovarian cancers.

Purpose of the Study:

  • To investigate the mechanism of As(2)O(3)-induced cell death in ovarian carcinoma.
  • To explore the role of TGFβ signaling mediators in As(2)O(3) treatment.
  • To identify novel therapeutic targets for ovarian cancer.

Main Methods:

  • Investigated the effects of As(2)O(3) on TGFβ signaling mediators.
  • Analyzed As(2)O(3)'s impact on Beclin 1 and autophagic pathways.
  • Examined the modulation of SnoN/SkiL expression by As(2)O(3).

Main Results:

  • As(2)O(3) induces cell death in ovarian carcinoma cells.
  • The cell death pathway is independent of Beclin 1.
  • As(2)O(3) modulates SnoN/SkiL expression, suggesting a role in the autophagic process.

Conclusions:

  • As(2)O(3) triggers a Beclin 1-independent autophagic pathway in ovarian cancer cells.
  • SnoN/SkiL modulation is a key component of As(2)O(3)'s mechanism of action.
  • SnoN represents a potential novel therapeutic target for ovarian cancer treatment.

More Related Videos

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on: June 30, 2023

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...